This article describes methods used to estimate parameters governing long-term survival, or times to other events, for health economic models. Specifically, the focus is on methods that …
Background This guideline focuses on long-term administration of antithrombotic drugs designed for primary and secondary prevention of cardiovascular disease, including two …
Abstract Aims Whilst the CArdiac REsynchronization in Heart Failure (CARE-HF) trial has shown that cardiac resynchronization therapy (CRT) leads to reduced morbidity and …
A Squizzato, M Bellesini, A Takeda… - Cochrane Database …, 2017 - cochranelibrary.com
Background Aspirin is the prophylactic antiplatelet drug of choice for people with cardiovascular disease. Adding a second antiplatelet drug to aspirin may produce additional …
Objective To estimate the incidence and HRs for bleeding for different dual antiplatelet therapies (DAPT) in a real-world population with acute coronary syndrome (ACS) …
M Jiang, JHS You - Cardiovascular drugs and therapy, 2017 - Springer
Purpose This study aimed to examine the cost-effectiveness of CYP2C19 loss-of-function and gain-of-function allele guided (LOF/GOF-guided) antiplatelet therapy in patients with …
Objetivo Evaluar la carga de enfermedad asociada al consumo de tabaco en Argentina y estimar el impacto sanitario y económico de aumentos de precio en los cigarrillos a través …
M Jiang, JHS You - Pharmacogenomics, 2016 - Taylor & Francis
Aim: This study aimed to compare the clinical and economic outcomes of pharmacogenetic- guided (PG-guided) and platelet reactivity testing-guided antiplatelet therapy for patients …